Delivery Order SPE2DB24D2205-SPE2DB25FEHRZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Buprenorphine 0.3 mg/mL vials with a ceiling value of $5,556.00. This is a firm fixed-price delivery order issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The award was not set aside and represents a competitive award to the prime contractor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.19 to AmerisourceBergen Drug Corp for the supply of Buprenorphine-Naloxone 12-3mg film strips (30-count packages) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 0.3 mg/mL buprenorphine vials. The contract has a ceiling value of $1,389.00 and a period of performance ending on June 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to provide $2,778 worth of Buprenorphine 0.3 mg/ml vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by December 12, 2023. No set-aside designation was applied to this award to...
- The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the supply of 30 buprenorphine 2 mg tablets. The firm fixed price order is to be performed in Conshohocken, Pennsylvania from July 13-14, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the opioid addiction treatment medication to support the Agency's health services for service members and their families. No set aside designation or...
- The Defense Logistics Agency awarded a $138,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.3 mg/ml buprenorphine vials. The single day contract has a period of performance from August 1-2, 2023, with all work to be conducted by the prime contractor at its Conshohocken, Pennsylvania facility. As the DLA supports military treatment programs, this award is likely associated with its pharmaceutical prime vendor indefinite-delivery/indefinite-quantity contract to...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,669 to Amerisourcebergen Drug Corporation for the supply of 30 units of 8-2mg films of buprenorphine-naloxone. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on July 28, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this...
- The Defense Logistics Agency Troop Support Medical awarded a $498 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 8 mg buprenorphine tablets. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 13, 2023 through July 14, 2023. This delivery order was issued against an existing DLA medical supply vehicle to fulfill the agency's near-term requirements for this pharmaceutical product. No subcontractors or set aside...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $69,450 firm fixed price delivery order by the Defense Logistics Agency to provide 4561346023 Buprenorphine 0.3 mg/ml vials. Performance will take place in Conshohocken, Pennsylvania over a one day period from June 27-28, 2023. The Defense Logistics Agency is the logistics combat support agency for the United States Department of Defense, responsible for worldwide logistical support including...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHRZDelivery Order
The Defense Logistics Agency awarded a $2,778.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Buprenorphine 0.3 mg/mL vials. This contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, involves no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, maintaining an extensive portfolio of medical product deliveries across multiple therapeutic domains. The company's SPE2DX contract with the Defense Logistics Agency functions as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This buprenorphine delivery order aligns with AmerisourceBergen's established role as a primary pharmaceutical vendor supporting Defense Health Agency procurement requirements and reflects the company's demonstrated capability to fulfill federal medical supply needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/17/25 |